Stay updated on Molidustat Efficacy in PD Anemia Clinical Trial
Sign up to get notified when there's something new on the Molidustat Efficacy in PD Anemia Clinical Trial page.

Latest updates to the Molidustat Efficacy in PD Anemia Clinical Trial page
- CheckyesterdayChange DetectedThe page displays the record for a completed Phase 3 study evaluating molidustat for renal anemia in people receiving peritoneal dialysis. It includes the study design, eligibility criteria, participating locations, and measured outcomes.SummaryDifference57%

- Check9 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check15 days agoChange DetectedAn NIH banner announces updates and FAQs about a terminology transition from “Artificial Intelligence” to “Super Intelligence.” It appears above the study page’s 403 error message.SummaryDifference1%

- Check22 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2 while the study page remains unavailable.SummaryDifference0.2%

- Check29 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check50 days agoChange DetectedThe page displays a 403 Forbidden error where the study details used to be, indicating the record is inaccessible. Users can no longer view essential trial information such as enrollment criteria, locations, or results for this study.SummaryDifference17%

Stay in the know with updates to Molidustat Efficacy in PD Anemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Molidustat Efficacy in PD Anemia Clinical Trial page.